Theravance Biopharma Inc.
8.64
0.11 (1.29%)
At close: Jan 15, 2025, 3:59 PM
8.61
-0.35%
After-hours Jan 15, 2025, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
Cash & Equivalents 39.55M 298.17M 89.96M 81.47M 58.06M 378.02M 88.98M 344.71M 112.71M 89.22M n/a n/a n/a
Short-Term Investments 62.88M 29.31M 83.51M 211.47M 222.77M 127.25M 259.59M 156.39M 59.73M 165.40M n/a n/a n/a
Long-Term Investments n/a 836.00K 67.54M 12.75M 4.99M 11.87M 41.59M 91.56M 50.86M 51.40M n/a n/a 1.13M
Other Long-Term Assets 203.10M 201.10M 4.07M 3.28M 6.11M 2.37M 10.91M 10.73M 1.91M -50.06M 833.00K -9.15M -1
Receivables 17.47M 16.79M 57.60M 69.67M n/a 10.67M 9.36M 9.72M 37.15M 2.13M 1.13M 941.00K 424.00K
Inventory n/a 1.51M 10.24M 20.37M 1.00 1.00 16.83M 12.22M 10.01M 12.55M 10.41M 7.51M n/a
Other Current Assets 13.64M 9.20M 18.81M 30.73M 57.66M 310.00K 3.99M 5.46M 17.88M 6.08M 2.57M 2.38M 1.89M
Total Current Assets 133.54M 353.46M 249.87M 393.34M 338.49M 532.82M 378.75M 528.50M 237.47M 326.77M 14.11M 10.84M 2.32M
Property-Plant & Equipment 45.35M 52.00M 53.35M 59.68M 59.25M 13.18M 10.16M 8.46M 9.87M 9.66M 10.24M 9.15M 10.37M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 248.46M 253.94M 124.95M 75.72M 70.34M 27.41M 62.65M 110.75M 62.64M 11.00M 11.07M 9.15M 11.50M
Total Assets 382.00M 607.40M 374.82M 469.06M 408.83M 560.24M 441.40M 639.25M 300.12M 337.77M 25.18M 20.96M 13.82M
Account Payables 1.52M 1.55M 3.10M 6.78M 4.76M 9.03M 5.92M 1.73M 18.80M 9.92M 6.94M 5.22M 5.71M
Deferred Revenue n/a 24.00K 98.00K 11.52M 31.57M 43.40M 125.00K 152.00K 144.00K 89.00K 8.21M n/a 12.98M
Short-Term Debt 3.92M 6.75M 17.44M 29.20M -20.42M n/a n/a n/a n/a n/a n/a n/a 69.00K
Other Current Liabilities 19.32M 20.38M 63.10M 116.91M 57.76M 46.12M 56.50M 47.38M 30.52M 31.25M 21.71M 17.45M 17.12M
Total Current Liabilities 24.77M 28.71M 58.59M 123.57M 111.70M 98.55M 62.55M 49.27M 49.47M 41.26M 36.85M 22.67M 35.88M
Long-Term Debt 45.24M 90.81M 652.08M 647.06M 492.92M 454.35M 223.75M 222.68M n/a n/a n/a n/a n/a
Other Long-Term Liabilities 99.00M 45.88M 2.42M 1.83M 21.29M 32.74M 39.92M 17.08M 7.58M 6.73M 5.36M n/a -1
Total Long-Term Liabilities 144.24M 136.88M 654.80M 649.24M 520.96M 513.27M 263.67M 239.75M 7.58M 6.73M 5.36M n/a 118.66M
Total Liabilities 169.00M 165.60M 713.39M 772.81M 632.67M 611.82M 326.22M 289.02M 57.05M 47.98M 42.21M 22.67M 154.54M
Total Debt 49.16M 74.12M 652.08M 647.06M 492.92M 454.35M 223.75M 222.68M n/a n/a n/a n/a 69.00K
Common Stock n/a 1K 1K 1K 1K 1K 1K 1K n/a n/a n/a n/a n/a
Retained Earnings -909.10M -853.91M -1.73B -1.53B -1.25B -1.01B -797.74M -512.23M -321.56M -139.34M -17.04M -6.99M -140.72M
Comprehensive Income -65.00K -15.00K -0.00 47.00K 145.00K -166.00K -733.00K -253.00K -70.00K -82.00K n/a n/a n/a
Shareholders Equity 213.00M 441.80M -338.57M -303.75M -223.84M -51.59M 115.18M 350.23M 243.06M 289.79M -17.04M -6.99M -140.72M
Total Investments 62.88M 29.31M 151.04M 224.22M 227.75M 139.12M 301.17M 255.95M 110.59M 216.79M n/a n/a 1.13M